Today's Alert

EVAHF is our Undervalued New Medical Marijuana Alert ready to bring CBD to the masses!

Posted on by in Todays Alert


USA: EVAHF   |  Canada: TMED
Last Price: .084  |  Website  |  SEC Filings  |  Latest News

There’s no doubt that the country is coming around to Legal/Medical Marijuana with all the health and pain medication benefits it provides.

And while Cannabis itself is not yet fully legal in every US StateCBD (Cannabidiol) is!

Cannabidiol is a phytocannabinoid discovered in 1940. It is one of some 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant’s extract. In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain.

Due in part to last year’s landmark Farm Bill which removed hemp as a Schedule I substance and reclassified it as an “agricultural commodity”, CBD that is derived solely from hemp is now Legal Nationwide!

All of this has spurred on a veritable arms race to dominate this potentially very lucrative market which is projected to exceed $3 BIL by 2021!

So needless to say, grabbing a unique foothold in this market NOW has never been more essential.  And that’s exactly what Today’s New Alert is doing…


Recently changing their name from Evitrade Health Systems Corp/Auxellence Health Corp, Theramed Health Corp. (EVAHF) is a unique company that melds Science, Health, BioTech, and CBD/Cannabis into one potentially GROUNDBREAKING situation!

EVAHF specializes in the Health and Life Sciences sector looking to deliver effective personalized CBD health solutions and products with a higher degree of predictability and consistency.

All of this is leading to the goal of becoming the FIRST TO OFFER a complete quality-assured vertically integrated ‘CBD Health System’ for monitoring and recording the effects of CBD on your cardiovascular system.

Sound Complex? 

Well that’s exactly why EVAHF is ahead of the game and could be FIRST to market!

YET….EVAHF has flown completely UNDER-THE-RADAR thus far as it trades at a mere 8 CENTS!

That’s why all of this and more could lead to a potentially EXPLOSIVE Situation in both the Short AND Long-Term!  So let’s dig in…..

Dual-Listed stocks sometimes don’t get the attention they deserve.

And while EVAHF is renowned on the Canadian Markets (CSE: TMED), it has been scantly noticed here in the US — even as it trades with the ‘upper crest’ of Small-Cap Stocks on the OTCQB Exchange.

Per our chart, the last few months have shown EVAHF slowly develop a descending Triangle Pattern.

As it approaches it’s zenith, could a Bullish Breakout be near?

We’ll be watching for a break of the upper trend line of our Triangle Pattern as well as the critical 50 Day Moving Average (read line) @ .11 to confirm a New Bullish Trend.

From there, we’ll be watching for a breach of the 200 Day Moving Average (yellow line) at around .18 to take it to the next level.

It’s important to note that EVAHF’s current 52 Week High is .4736 which is 463% HIGHER than the current price.

So what could potentially spur another rally?  Read on…

Theramed Health Corporation (EVAHF) – is a technology company specializing in the Health and Life Sciences sector looking to deliver effective personalized health solutions and products with a higher degree of predictability and consistency.

The company is looking to be the first to offer a complete quality assured vertically integrated ‘CBD Health System’ for monitoring and recording the effects of CBD on your cardiovascular system.

EVAHF is focused on the following areas to help improve health: 

► Personalized Medical Care:  The Company’s Autonomous Medical Care is engaged in the provision of biomedical online services for common health problems. This online system is aimed primarily at “practicing patients” interested in normalizing blood pressure, blood glucose, and body weight.

This includes health monitoring via the TULIP™ system that can be utilized for CBD usage monitoring for its effects on your cardiovascular and endocannabinoid system.

TULIP™ is a medical device previously cleared for sales in Canada and Europe as a blood pressure monitor with interactive protocols.

► Molecular BiologyThe Company is investigating the impact of increasing the bio-availability of nutraceutical based protocols through the enhancement of molecular structures or delivery systems.

One such is a novel slow release pharmaceutical carrier system to increase water solubility and absorption of CBD or other Active Pharmaceutical Ingredients.

► Pharmaceutical & Nutraceutical Solutions: The Company is investigating the health effects of various natural remedies on the health of consumers either alone or in conjunction with other elements.  In focus are various plant based products that are targeted to relieve symptoms such as:  Anxiety, Sleeplessness, Chronic inflammation, Fatigue, and High Cholesterol.  Initial projects will include Astaxanthin, Spirulina and eventually Cannabinoids.

This includes CBD extractions for improved purity and extractions of nutraceutical solutions and other Active Pharmaceutical Ingredients.

► Genetic SelectionThe Company is researching work projects that are focused on creating a homogeneous library of plants through the study and augmentation of the plants core genetics.

, through it’s subsidiary, Western Agri Solutions Supply Corp, also has a joint venture with a LICENSED Nevada hemp operator to develop a Hemp Extraction Facility.

Through this joint venture, the companies can buy raw hemp and process it through state regulated extraction methodologies.

Already, the companies have performed their first run of its new hemp processing system that provided a crude to distillate run that exceeded expectations. The tests indicated high levels of CBD content which could provide a competitive edge in the marketplace against other competing brands.

Based on these results, EVAHF expects to be starting with a base level of production by the end of this month!

When completed, the facility will be able to process enough hemp to produce approximately 200KG’s of CBD isolate per month!

With this volume of throughput, EVAHF believes they will be able to satisfy their sales channels with it’s own line of premium CBD based products subject to applicable federal and local laws.

EVAHF may have some lofty goals but the company truly appears poised to reach them, and in some instances EXCEED them!

With the company’s recent Joint Venture noted above, they are now positioned to access enough hemp to process highly valuable CBD isolate – as part of their plan to bring premium CBD-based products to market and custom-tailor personalized CBD Health Solutions through a “CBD Health System”.

Needless to say, this is a unique niche’ in the CBD Market that we haven’t seen before — and one that could eventually be utilized in other extracts like THC and more upon nationwide Cannabis legalization!

So it’s clear EVAHF is setting up for a BIG FUTURE.

And at just around 8 CENTS with a potential BREAKOUT Chart Pattern, there may be no better time to check out this high-growth play in both the short and long-term!

Make sure you put EVAHF on your screen RIGHT NOW and Follow on Twitter for Updates + Play-by-Play!

Good Trading,

Don “The Donald” Fitzgerald
Editor |

All Content, Distribution, and editorial control has been given, reviewed, and approved by Theramed Health Corporation. does not own any shares of EVAHF. has been compensated one-hundred and eighty thousand dollars cash via bank wire by Theramed Health Corporation for a one week advertising services contract.  Please Read Full Disclaimer Below.

Need an Online Broker to trade Pot Stocks?
“The Donald” HIGHLY recommends ETRADE! 

Home  |  Trading School  |  Twitter  |  Disclaimer  |  Contact  |  UNSUBSCRIBE |  View in Browser

Please read our Full Disclaimer:

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.

PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED at &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS.

You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe HERE.

This Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Link Media and/or it’s subscriber base. Our website and newsletter are for Entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at

We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.

Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by or an offer or solicitation to buy or sell any security.

COMPENSATION: has been compensated one-hundred and eighty thousand dollars cash via bank wire by Theramed Health Corporation for a one week advertising services contract. does not own any shares of EVAHF.

All Content, Distribution, and editorial control has been given, reviewed, and approved by Theramed Health Corporation. does not investigate the background of any publicly traded company or third party. They may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. is compliant with the Can Spam Act of 2003. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.

In preparing this publication, has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised herein, nor is responsible for any other promotional firm, its program or its structure.